TSX:CURAPharmaceuticals
Curaleaf Holdings Q4 Loss Narrows To US$11.9 Million Challenging Bearish Profitability Narratives
Curaleaf Holdings (TSX:CURA) has just closed out FY 2025 with Q4 revenue of US$323.4 million and a basic EPS loss of US$0.02, alongside net income from continuing operations showing a loss of US$11.9 million and earnings from discontinued operations posting a further loss of US$15.7 million. The company has seen quarterly revenue hold in a tight band over the past year, from US$331.1 million in Q4 2024 through US$310.0 million in Q1 2025. Basic EPS losses ranged between US$0.11 and US$0.02...